ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

ABDALLAH RIMAWI MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,873Medicare Part D Prescriptions Filled, Including Refills

Rank: 1376 out of 5176

$341K Total Retail Price of All Prescriptions

Rank: 2031 out of 5176

312 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 312 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 312 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 6,467 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 298 288 1 8
LEVOTHYROXINE SODIUM 274 265 2 4
WARFARIN SODIUM 249 249 3 13
LISINOPRIL 213 209 4 5
METOPROLOL TARTRATE 197 194 5 6
OMEPRAZOLE 192 189 6 3
DONEPEZIL HCL 192 192 6 28
MIRTAZAPINE 189 185 8 45
NAMENDA 171 171 9 47
AMLODIPINE BESYLATE 166 148 10 2
GABAPENTIN 156 144 11 21
PANTOPRAZOLE SODIUM 117 106 12 61
DIGOXIN 96 96 13 56
CITALOPRAM HBR 87 87 14 31
HYDROCODONE-ACETAMINOPHEN 86 80 S3 15 27
POTASSIUM CHLORIDE 80 79 16 34
CIPROFLOXACIN HCL 77 66 17 84
SIMVASTATIN 77 77 17 1
RISPERIDONE 76 76 19 78
FINASTERIDE 70 70 20 69
CYMBALTA 70 53 20 90
METFORMIN HCL 68 68 22 7
CARBIDOPA-LEVODOPA 63 62 23 98
LIDOCAINE 63 63 23 179
BACLOFEN 62 47 25 173
LEVETIRACETAM 60 51 26 92
HYDROCHLOROTHIAZIDE 60 57 26 10
JANTOVEN 59 58 28 106
CARVEDILOL 55 54 29 24
OXYBUTYNIN CHLORIDE ER 54 52 30 204
CEPHALEXIN 53 51 31 189
ATENOLOL 51 51 32 12
IPRATROPIUM-ALBUTEROL 50 47 33 138
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.